SCAND.MEDICAL SOL.DK-040
Scandinavian Medical Solutions A/S deals in medical imaging equipment worldwide. The company offers equipment in the categories of Cath Lab, CT, mammogram, PET/CT, Spect/CT, X-ray, ultrasound, MRI, Gamma/Spect, C-arm, mobile X-ray, R/F, mobile solutions, and others, as well as provides CT, MRI, Cath Lab, X-ray, mammography, ultrasound PET/CT, and C-arm parts. It also provides rental solutions. Th… Read more
Market Cap & Net Worth: SCAND.MEDICAL SOL.DK-040 (K41)
SCAND.MEDICAL SOL.DK-040 (F:K41) has a market capitalization of $11.57 Million (€11.27 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #46326 globally and #7709 in its home market, demonstrating a -2.40% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SCAND.MEDICAL SOL.DK-040's stock price €0.41 by its total outstanding shares 27687333 (27.69 Million).
SCAND.MEDICAL SOL.DK-040 Market Cap History: 2022 to 2026
SCAND.MEDICAL SOL.DK-040's market capitalization history from 2022 to 2026. Data shows change from $25.61 Million to $11.57 Million (-9.30% CAGR).
SCAND.MEDICAL SOL.DK-040 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SCAND.MEDICAL SOL.DK-040's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of K41 by Market Capitalization
Companies near SCAND.MEDICAL SOL.DK-040 in the global market cap rankings as of March 19, 2026.
Key companies related to SCAND.MEDICAL SOL.DK-040 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
SCAND.MEDICAL SOL.DK-040 Historical Marketcap From 2022 to 2026
Between 2022 and today, SCAND.MEDICAL SOL.DK-040's market cap moved from $25.61 Million to $ 11.57 Million, with a yearly change of -9.30%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €11.57 Million | -30.07% |
| 2025 | €16.54 Million | -17.80% |
| 2024 | €20.12 Million | -28.19% |
| 2023 | €28.02 Million | +9.43% |
| 2022 | €25.61 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of SCAND.MEDICAL SOL.DK-040 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $11.57 Million USD |
| MoneyControl | $11.57 Million USD |
| MarketWatch | $11.57 Million USD |
| marketcap.company | $11.57 Million USD |
| Reuters | $11.57 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.